| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 2 | |
| #3 | South Africa | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | EAPO (Eurasian Patent Organization) | 1 | |
| #9 | Hong Kong | 1 | |
| #10 | Israel | 1 | |
| #11 | Republic of Korea | 1 | |
| #12 | Mexico | 1 | |
| #13 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Prades Cosano Roger | 13 |
| #2 | Tarragó Clua María Teresa | 6 |
| #3 | Seco Moral Jesus | 5 |
| #4 | Tarrago Clua Maria Teresa | 5 |
| #5 | Seco Moral Jesús | 4 |
| #6 | Roger Prades Cosano | 4 |
| #7 | Pallara Chiara | 2 |
| #8 | Jesús Seco Moral | 2 |
| #9 | María Teresa Tarragó Clua | 2 |
| #10 | Llorente Cortés Vicenta | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP3736284A1 | Vascular cholesterol inhibitors and use thereof | |
| BR112018009641A2 | gelatinase inhibitors and their use | |
| EP3031458A1 | Use of 1-[(2-phenylcycloprop-1-yl)carbonyl]-2-[(1,3-thiazolidin-3-yl)carbonyl]perhydroindole in the treatment of schizophrenia-associated cognitive deficits |